NAS:CDMO (USA)
Business Description
Avid Bioservices Inc
NAICS : 325412
SIC : 2834
2642 Michelle Drive, Suite 200, Tustin, CA, USA, 92780
Description
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.69 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 1.05 | |||||
| Debt-to-EBITDA | 9.45 | |||||
| Interest Coverage | 7.1 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.03 | |||||
| Beneish M-Score | 17.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21 | |||||
| 3-Year FCF Growth Rate | -41.7 | |||||
| 3-Year Book Growth Rate | 44 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 22.57 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.48 | |||||
| 9-Day RSI | 51.21 | |||||
| 14-Day RSI | 53.62 | |||||
| 6-1 Month Momentum % | -10.59 | |||||
| 12-1 Month Momentum % | -28.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 2.03 | |||||
| Cash Ratio | 1.67 | |||||
| Days Inventory | 83.2 | |||||
| Days Sales Outstanding | 63.41 | |||||
| Days Payable | 39.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.64 | |||||
| Operating Margin % | 12.89 | |||||
| Net Margin % | 106.75 | |||||
| ROE % | 157.78 | |||||
| ROA % | 40.36 | |||||
| ROIC % | 87.82 | |||||
| ROC (Joel Greenblatt) % | 16.44 | |||||
| ROCE % | 6.05 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.28 | |||||
| Forward PE Ratio | 61.42 | |||||
| PE Ratio without NRI | 10.28 | |||||
| Price-to-Owner-Earnings | 16.79 | |||||
| PS Ratio | 11 | |||||
| PB Ratio | 6.75 | |||||
| Price-to-Tangible-Book | 6.75 | |||||
| Price-to-Operating-Cash-Flow | 130.41 | |||||
| EV-to-EBIT | 83.16 | |||||
| EV-to-EBITDA | 63.9 | |||||
| EV-to-Revenue | 10.33 | |||||
| EV-to-Forward-Revenue | 8.55 | |||||
| EV-to-FCF | -26.11 | |||||
| Price-to-Median-PS-Value | 1.61 | |||||
| Price-to-Graham-Number | 1.76 | |||||
| Earnings Yield (Greenblatt) % | 1.21 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:CDMO
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 119.597 | ||
| EPS (TTM) ($) | 1.85 | ||
| Beta | 1.93 | ||
| Volatility % | 77.15 | ||
| 14-Day RSI | 53.62 | ||
| 14-Day ATR ($) | 1.025025 | ||
| 20-Day SMA ($) | 19.0325 | ||
| 12-1 Month Momentum % | -28.38 | ||
| 52-Week Range ($) | 11.3 - 34.51 | ||
| Shares Outstanding (Mil) | 61.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avid Bioservices Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||